Cargando…

Projecting COVID-19 Mortality as States Relax Nonpharmacologic Interventions

IMPORTANCE: A key question for policy makers and the public is what to expect from the COVID-19 pandemic going forward as states lift nonpharmacologic interventions (NPIs), such as indoor mask mandates, to prevent COVID-19 transmission. OBJECTIVE: To project COVID-19 deaths between March 1, 2022, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Linas, Benjamin P., Xiao, Jade, Dalgic, Ozden O., Mueller, Peter P., Adee, Madeline, Aaron, Alec, Ayer, Turgay, Chhatwal, Jagpreet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976243/ https://www.ncbi.nlm.nih.gov/pubmed/35977324 http://dx.doi.org/10.1001/jamahealthforum.2022.0760

Ejemplares similares

Assessment of Incidence of and Surveillance Burden for Hepatocellular Carcinoma Among Patients With Hepatitis C in the Era of Direct-Acting Antiviral Agents
por: Chen, Qiushi, et al.
Publicado: (2020)

Association of Limited In-Person Attendance in US National Football League and National Collegiate Athletic Association Games With County-Level COVID-19 Cases
por: Toumi, Asmae, et al.
Publicado: (2021)

PIN68 COVID-19 Simulator: An Interactive Tool to Inform COVID-19 Intervention Policy Decisions in the United States
por: Chhatwal, J., et al.
Publicado: (2020)

Estimated Reductions in Opioid Overdose Deaths With Sustainment of Public Health Interventions in 4 US States
por: Chhatwal, Jagpreet, et al.
Publicado: (2023)

Improved Health Outcomes from Hepatitis C Treatment Scale-Up in Spain’s Prisons: A Cost-Effectiveness Study
por: Dalgic, Ozden O., et al.
Publicado: (2019)

Analysis of a Simulation Model to Estimate Long-term Outcomes in Patients with Nonalcoholic Fatty Liver Disease
por: Chhatwal, Jagpreet, et al.
Publicado: (2022)

Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan
por: Chhatwal, Jagpreet, et al.
Publicado: (2019)

When Can We Lift Non‐Pharmaceutical Interventions with the Availability of COVID‐19 Vaccine in the United States?
por: Chhatwal, Jagpreet, et al.
Publicado: (2021)

Reduction of COVID-19 Incidence and Nonpharmacologic Interventions: Analysis Using a US County–Level Policy Data Set
por: Ebrahim, Senan, et al.
Publicado: (2020)

Assessing cost-effectiveness of hepatitis C testing pathways in Georgia using the Hep C Testing Calculator
por: Adee, Madeline, et al.
Publicado: (2021)

Author Correction: Assessing cost-effectiveness of hepatitis C testing pathways in Georgia using the Hep C Testing Calculator
por: Adee, Madeline, et al.
Publicado: (2022)

Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India
por: Aggarwal, Rakesh, et al.
Publicado: (2017)

Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States
por: Chen, Qiushi, et al.
Publicado: (2019)

A clash of epidemics: Impact of the COVID-19 pandemic response on opioid overdose
por: Linas, Benjamin P., et al.
Publicado: (2021)

Factors associated with receipt of second-line recurrent or metastatic cervical cancer treatment in the United States: A retrospective administrative claims analysis
por: Sonawane, Kalyani, et al.
Publicado: (2022)

Factors associated with receipt of second-line recurrent or metastatic cervical cancer treatment in the United States: A retrospective administrative claims analysis
por: Sonawane, Kalyani, et al.
Publicado: (2022)

Projected Estimates of Opioid Mortality After Community-Level Interventions
por: Linas, Benjamin P., et al.
Publicado: (2021)

Comparison of a multitarget blood test to ultrasound and alpha‐fetoprotein for hepatocellular carcinoma surveillance: Results of a network meta‐analysis
por: Singal, Amit G., et al.
Publicado: (2022)

Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study
por: Chen, Qiushi, et al.
Publicado: (2019)

Evaluation of Nonpharmacologic Interventions and Sleep Outcomes in Hospitalized Medical and Surgical Patients: A Nonrandomized Controlled Trial
por: van den Ende, Eva S., et al.
Publicado: (2022)

Nonpharmacological interventions in COPD
por: Janssens, Wim, et al.
Publicado: (2023)

Substitution of Nonpharmacologic Therapy With Opioid Prescribing for Pain During the COVID-19 Pandemic
por: Lee, Byungkyu, et al.
Publicado: (2021)

Trends in the Use of Opioids vs Nonpharmacologic Treatments in Adults With Pain, 2011-2019
por: Pritchard, Kevin T., et al.
Publicado: (2022)

Effectiveness of HCC surveillance programs using multitarget blood test: A modeling study
por: Chhatwal, Jagpreet, et al.
Publicado: (2023)

Coverage of Nonpharmacologic Treatments for Low Back Pain Among US Public and Private Insurers
por: Heyward, James, et al.
Publicado: (2018)

Health Economics of Interventions to Tackle the Coronavirus 2019 Pandemic
por: Chhatwal, Jagpreet, et al.
Publicado: (2021)

Nonpharmacologic Interventions in Prevention and Treatment of Hypertension
por: Erejuwa, Omotayo O., et al.
Publicado: (2019)

Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis
por: Klebanoff, Matthew J., et al.
Publicado: (2019)

Hypoxic exercise as an effective nonpharmacological therapeutic intervention
por: Brocherie, Franck, et al.
Publicado: (2020)

Nonpharmacological Treatment of Persistent Postconcussion Symptoms in Adults: A Systematic Review and Meta-analysis and Guideline Recommendation
por: Rytter, Hana Malá, et al.
Publicado: (2021)

Alcohol-Associated Liver Disease Mortality Rates by Race Before and During the COVID-19 Pandemic in the US
por: Kulkarni, Neeti S., et al.
Publicado: (2023)

A multimorbidity model for estimating health outcomes from the syndemic of injection drug use and associated infections in the United States
por: Chiosi, John J., et al.
Publicado: (2023)

Erratum to “Nonpharmacologic Interventions in Prevention and Treatment of Hypertension”
por: Erejuwa, Omotayo O., et al.
Publicado: (2019)

Racial and Ethnic Differences in Receipt of Nonpharmacologic Care for Chronic Low Back Pain Among Medicare Beneficiaries With OUD
por: Bhondoekhan, Fiona, et al.
Publicado: (2023)

Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?
por: Chhatwal, Jagpreet, et al.
Publicado: (2022)

Cost-effectiveness of Screening for Atrial Fibrillation Using Wearable Devices
por: Chen, Wanyi, et al.
Publicado: (2022)

Nonpharmacological treatment of epilepsy
por: Saxena, V. S., et al.
Publicado: (2011)

Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus–Associated Cancers
por: Suk, Ryan, et al.
Publicado: (2018)

COVID-19 Health Economics: Looking Back and Scoping the Future
por: Postma, Maarten J., et al.
Publicado: (2022)

What Is the Optimal Threshold at Which to Recommend Breast Biopsy?
por: Burnside, Elizabeth S., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_j99rm1311udfrmmi5vsvgrb51u